Weirich Gregor, Klein Bettina, Wöhl Thorsten, Engelhardt Dieter, Brauch Hiltrud
Institute of Pathology, Technische Universität München, D-81675 Munich, Germany.
J Clin Endocrinol Metab. 2002 Nov;87(11):5241-6. doi: 10.1210/jc.2002-020651.
Von Hippel-Lindau disease (VHL) is a multitumor syndrome that develops on the basis of germline mutations in the VHL tumor suppressor gene. Genotype-phenotype correlations have helped to stratify the disease into VHL type 1 (without pheochromocytoma) and VHL type 2A, 2B, and 2C (with pheochromocytoma). VHL2C is characterized by a pheochromocytoma-only phenotype. We report on the P81S germline mutation in a German VHL2C family with the previously identified L188V mutation. The concurrent P81S mutation was identified by novel screening approaches including denaturing HPLC and sequencing. We show the co-segregation of these two mutations with the disease and discuss their possible impact on pVHL function and phenotype.
冯·希佩尔-林道病(VHL)是一种多肿瘤综合征,它基于VHL肿瘤抑制基因的种系突变而发生。基因型与表型的相关性有助于将该疾病分为VHL 1型(无嗜铬细胞瘤)和VHL 2A、2B及2C型(有嗜铬细胞瘤)。VHL2C的特征是仅表现为嗜铬细胞瘤的表型。我们报告了一个德国VHL2C家族中的P81S种系突变,该家族中先前已鉴定出L188V突变。通过包括变性高效液相色谱法和测序在内的新型筛查方法鉴定出了同时存在的P81S突变。我们展示了这两种突变与疾病的共分离情况,并讨论了它们对pVHL功能和表型可能产生的影响。